Business & Scientific Resources

Your Company's Response to Coronavirus

As cases of coronavirus (COVID-19) continue to increase around the world, this resource center is designed to keep you informed on key information to keep your employees safe and business operating. This information will be regularly updated, check back often.

  • Show All
Search
Results
AHRQ intends to allow grantees with active AHRQ research grants to submit requests for competitive revision supplements. 
NIAID is issuing this Notice of Special Interest (NOSI) to highlight the need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19).
NIAID is issuing this NOSI to highlight the need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19).
NSF is currently funding 20 research projects across the agency involving COVID-19.  
The purpose of this Funding Opportunity Announcement (FOA) is to provide an expedited funding mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19).
The purpose of this Funding Opportunity Announcement (FOA) is to provide an expedited funding mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19).
The purpose of this FOA is to solicit research applications for milestone-driven projects focused on preclinical development of lead candidate therapeutics, vaccines and related countermeasures against select NIAID Emerging Infectious Diseases/Pathogens. 
AHA invites cardiovascular-focused applications that will contribute to understanding the cardiovascular and cerebrovascular pathogenesis, diagnosis, prevention, clinical manifestations, clinical management and social behaviors which can lead to complications of COVID-19
At Arnold & Porter, we are client-driven and industry-focused. Our lawyers practice in more than 40 practice areas across the litigation, regulatory and transactional spectrum to help clients with complex needs stay ahead of the global market, anticipate opportunities and address issues that…
Elrha is launching an urgent funding call for research proposals to support the COVID-19 response in humanitarian settings.
The Board’s decision enables CIRM to allocate $5 million in funding for peer-reviewed regenerative medicine and stem cell research that could quickly advance treatments for COVID-19. 
The Arizona COVID-19 Community Response Fund provides immediate relief to nonprofit organizations in Arizona facing an increased demand for services from clients and communities as a result of the COVID-19 outbreak.
Last update: Monday, January 25, 2021 @ 4:42 pm EST